Ethical issues in organ transplantation

Medical Principles and Practice

Volumn 12, Issue 1, 2003, Pages 54-69

  Abouna, George M ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Donor compensation; Fetal tissue; Living versus cadaver donor transplantation; Organ allocation; Organ sale; Stem cells; Xenotransplantation

Indexed keywords

CADAVER DONOR; CLONING; DEATH CERTIFICATE; FINANCIAL MANAGEMENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL ETHICS; MORALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PRISONER; RELIGION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; XENOTRANSPLANTATION;

HEALTH CARE AND PUBLIC HEALTH;

ANIMALS; COMMERCE; HUMANS; ORGAN TRANSPLANTATION; PRESUMED CONSENT; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES;

EID: 0037258225     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068158     Document Type: Review

References (71)

1. Cecka JM, Trasaraki PI: Clinical Transplantation 2000. Los Angeles, UCLA Tissue Typing Lab, 2000.
2. Cooper L, Neumann ME: Renal data statistics. Part II. The bigger picture. Nephrol News Issues 2001;15:73-77.
3. Abouna GM: The humanitarian aspects of organ transplantation. Transpl Int 2001;14:117-123.
4. Merrill JP, Murray JE, Harrison JH, Guild WR: Successful homotransplantation of human kidneys between identical twins. Am J Surg 1958;148:343.
5. United Network for Organ Sharing (UNOS): Annual Report, 1999.
6. United Network for Organ Sharing (UNOS): 'Update', special edition, Winter 2002.
7. Keown P: Improving the quality of life: The new target for transplantation. Transplantation 2001;7:S67-S74.
8. Eggers PW: Effect of transplantation on the Medicare End Stage Renal Disease Program. N Engl J Med 1998;38:223-229.
9. Hunsicker LG: Survival advantage for renal transplantation. N Engl J Med 1999;341:1762-1763.
10. Caplan AL, Coehlo OH: The Ethics of Organ Transplantation: The Current Debate. New York, Prometheus Books, 1998, pp 9-12.
11. Jarvis R: Join the club: A modest proposal to increase availability of donor organs. J Med Ethics 1995;21:199-204.
12. Abouna GM: Recent Pronouncements by Two Major Religions on Organ Transplantation: Current Status of Clinical Organ Transplantation. The Hague, Nijhoff, 1984, pp XI-XII.
13. Cohen B, D'Amaro J: Some contemporary ethical consideration related to organ transplantation. Transpl Int 1995;8:238-243.
14. United Network for Organ Sharing (UNOS): Policy of Organ Distribution. June 2001.
15. Cerilli J: Ethical guidelines for organ procurement. Transplantation 1988,46:171-172.
16. Evans RW: Organ transplantation and the inevitable debate as to what constitutes basic health care benefit. Clin Transpl 1993:359-391.
17. Weinstock JL, Vice President, Gift of Life Donor Program, Philadelphia, 2002 (personal communication).
18. Abouna GM: Marginal donors: A viable solution for organ shortage. Transplant Proc 1997;29:2759-2765.
19. Turcotte JT, Benjamin M, Caplan AL: Patient selection criteria in organ transplantation: The critical questions. Transplant Proc 1989;21:3377-3445.
20. Ethical considerations in the allocation of organs and other scarce medical resources among patients. Am Med Assoc Rep 49. Arch Intern Med 1995;155:29-40.
21. Matas AJ, Delmonico FL: Transplant kidneys sooner: Discard fewer kidneys. Am J Transplant 2001;1:301-304.
22. Gow PJ, Pillat D, Multimer D: Solid organ transplantation in patients with HIV infection. Transplantation 2001;72:177-181.
23. The Definition of Irreversible Coma: Report of ad hoc Committee of Harvard Medical School of Definition of Brain Death. JAMA 1968;205:337.
24. Norton DL: Clinical application of brain death protocol. J Neurosci Nurs 1992;24:354-358.
25. Medearis DN Jr, Hommes LB: On the use of anencephalic infants as organ donors. N Engl J Med 1989;321:391-393.
26. Abouna GM: Kidney transplantation from live donors: Benefits, possible risks and dilemmas. J Kuwait Med Assoc 1998;30:89-92.
27. Abouna GM, Panjwani D, Kumar MS, White AG, Al-Abdulla IH, Silva OS, Samham M: The living unrelated donor: A viable alternative for renal transplantation. Transplant Proc 1988;20:802-804.
28. Spitall A: Evolution of attitudes at US transplant centers toward kidney donation by friends and altruistic strangers. Transplantation 2000;69:1728-1731.
29. Landolt MA, Henderson SJ, Barrable WM, Greenwood SD, McDonald MF, Soos JG, Landsberg DN: Living anonymous kidney donation: What does the public think? Transplantation 2001;71:1690-1696.
30. Consensus Statement on the Live Organ Donors. JAMA 2000:284:2919-2926.
31. Safety of cells, tissues and organs for transplantation: General requirements. Can Standard Assoc Bull Nov 2001;8-64.
32. Marlago M, Broelsh CE: Living related liver transplantation. Transplant Proc 1994;26:3620-3624.
33. Cronin D, Mills JM, Siegler M: Transplantation of liver graft from living donors into adults: Too much too soon. N Engl J Med 2001;344:1633-1637.
34. Broering DC, Mueller L, Ganschow R, Kim JS, Achilles EG, Schafer H, Gundlach M, Fischer L, Sternech M, Hillert C, Helmke C, Izbicki JR, Burdelski M, Rogiers X: Is there still a need for living related liver transplantation in children? Ann Surg 2001;23:713-721.
35. Adams MB, Nicole M, Martyh M: Living donor liver transplantation. Curr Opin Organ Transplant 2001;6:363-366.
36. Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlewaite JR, Broelsch CE: Ethics of liver transplantation with living donors. N Engl J Med 1989;321:620-622.
37. Strong RW: Death after the living related liver transplantation. Liver Transpl 2000;6:250.
38. Abouna GM: Emergency adult living donor liver transplantation: Is it justifiable? Transplantation 2001;71:1498-1500.
39. Peters TG: Life or death: The issue of payment in cadaveric organ donation. JAMA 1991;265:1302-1305.
40. Reedy KC: Should paid organ donation be banned in India: To buy or let die. Natl Med J India 1993;6:137-139.
41. Miller DB: Ethics of paid organ donation and the use of executed prisoners as donors. Kidney Int 1999;55:733-737.
42. Abouna GM: Moral, ethical and medical values sacrificed by commercialization in human organs; in Abouna GM, Kumar AG (eds): Organ Transplantation. Norwell, Kluwer, 1991, pp 543-545.
43. Sheil R: Policy statement from the ethics committee from the Transplantation Society. Transplant Soc Bull 1995;3:3.
44. Radcliffe-Richards J, Daar AS, Guttmann RD, Hoffenberg R, Kennedy I, Lock M, Sells RA, Tilney N: The case for allowing kidney sales. Lancet 1998;351:1950-1952.
45. Cameron JS, Hoffenberg R: Ethics of organ transplantation reconsidered: Paid organ donation and the use of executed prisoners as donors. Kidney Int 1999;55:724-732.
46. Thomas C: Living donor receive leave benefits. Transplant Chronicle 2000;7:4.
47. Amerling R: A market for living organs revisited. Transplant News Issues 2001;2:S16-S17.
48. Coutts MS: Fetal Tissue Research. Scope Note 21, Kennedy Institute of Ethics, March 1993.
49. Niklason LA, Langer RL: Prospects for organ and tissue replacement. JAMA 2001;285:573-576.
50. Gale RP: Cord blood cell transplantation: A real sleeper. N Engl J Med 1995;332:392-394.
51. Fine A: Human fetal research: Practice, prospects and policy. Cell Transplant 1994;3:113-145.
52. Zamir G: Gene therapy and graft mortification. Curr Opin Organ Transplant 2001;6:343.
53. Fandrich F: Pre-implantation stage stem cells induce allogeneic graft acceptance with host conditioning. Nat Med 2002;8:171.
54. Eradini S: Stem cells for all seasons? Experimental and clinical issues. JR Soc Med 2002;95:5-8.
55. Machalinski D, Kijowski J, Marlitz W, Markiewski M, Paczkowski M, Kopkowski A, Majka M, Ostrowski M, Ratajczak MZ: Heparinized cadaveric organ as a potential source of hematopoietic cells for transplantation and gene therapy. Transplantation 2001;71:1003-1007.
56. Bartholomew A, Sher D, Sosler S, Stock W, Lazda V, Koshy M, Devine S, van Besien K: Stem cell transplantation eliminates allo-antibody in a highly sensitized patient. Transplantation 2001;72:1653-1655.
57. Grant D, Mendicino M, Levy G: Xenotransplantation: Just around the corner? Surgery 2001;129:243-247.
58. Bukler L, Cooper DK: Xenotransplant: State of the art. Front Biosci 1999;4:416.
59. Abouna GM: The use of ex-vivo xenogeneic whole liver perfusion as a bridge to liver regeneration or liver transplantation. Graft 2001;4:120-125.
60. Abouna GM, Fisher LM, Still WJ, Hume DM: Acute hepatic coma successfully treated by ex-tracorporeal baboon liver perfusions. BMJ 1972;1:23-25.
61. Abouna GM: Long-term hepatic support by multi-species liver perfusion. Lancet 1970; ii:391.
62. Levy M, et al: Liver transplant after extracorporeal hepatic support with transgenic porcine liver. Transplantation 2000;69:272.
63. Starzl T, et al: Renal transplantation from baboon to man: Experience with six cases. Transplantation 1964;2:752.
64. Starzl T, et al: Baboon to human transplantation. Lancet 1993;341:65.
65. Heneine W, Tibell A, Switzer WM, Sandstrom P, et al: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998;352:695-699.
66. Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME: No evidence of pig DNA or retroviral infections in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998;352:699-701.
67. Martin N, et al: Porcine endogenous retrovirus (PERV) was not transmitted from transplant porcine endothelial to baboon in-vivo. Transpl Int 1998;11:247.
68. Platt JL: Genetic engineering for xenotransplantation. Transplant Proc 1999;3:1488.
69. Institute of Medicine (IOM): Xenotransplantation, Science, Ethics and Public Policy. Washington, National Academy Press, 1996.
70. Bishop LJ: Animal Research and Education: Ethical Issues. Scope Note 46, Kennedy Institute of Bioethics, 2001, p 3-6.
71. United Network for Organ Sharing (UNOS): Update, Jan 2000, p 17.